Effects of anti-CD20 treatment beyond B cell depletion: Reduction of endogenous sTACI

被引：0

作者：

Mader, Simone ^{[1
]}

Thaler, Franziska ^{[1
,2
]}

Fichtner, Miriam ^{[1
]}

Ho, Samantha ^{[1
]}

Oswald, Eva ^{[1
]}

Wong, Hoi Kiu ^{[1
]}

Vural, Atay ^{[3
]}

Yilmaz, Vuslat ^{[4
]}

Tuezuen, Erdem ^{[4
]}

Turkoglu, Recai ^{[5
]}

Straub, Tobias ^{[6
]}

Smolle, Michalea ^{[7
]}

Schaller, Jonas ^{[1
]}

Feederle, Regina ^{[8
]}

Bultmann, Andreas ^{[9
]}

Schneider, Pascal ^{[10
]}

Meinl, Ingrid

Kuempfel, Tania

Meinl, Edgar ^{[1
]}

机构：

[1] Ludwig Maximilians Univ Munchen, Inst Clin Neuroimmunol, Biomed Ctr & Univ Hosp, Munich, Germany

[2] Munich Cluster Syst Neurol SyNergy, Munich, Germany

[3] Koc Univ, Dept Neurol, Sch Med, Istanbul, Turkiye

[4] Aziz Sancar Inst Expt Med, Dept Neurosci, Istanbul, Turkiye

[5] Haydarpasa Numune Educ & Res Hosp, Dept Neurol, Istanbul, Turkiye

[6] Ludwig Maximilians Univ Munchen, Biomed Ctr, Core Facil Bioinformat, Martinsried, Germany

[7] Ludwig Maximilians Univ Munchen, Physiol Chem, BMC, Martinsried, Germany

[8] German Res Ctr Environm Hlth, Monoclonal Antibody Core Facil, Helmholtz Zentrum Munchen, Neuherberg, Germany

[9] MorphoSys AG, Planegg, Germany

[10] Univ Lausanne, Dept Immunobiol, Lausanne, Switzerland

来源：

MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P685/217

引用

页码：592 / 593

页数：2

共 50 条

[31] Effect of Subcutaneous Treatment With Anti-CD20 Antibody on B-cell Depletion in a Lipopolysaccharide-Induced Inflammatory Mouse Model
Dawson, Janet
Touil, Ismahane
Scheidegger, Anja
Vogelsanger, Melanie
Leppert, David
Weckbecker, Gisbert
NEUROLOGY, 2019, 92 (15)
[32] A Phase I trial of B-cell depletion with anti-CD20 monoclonal antibody (rituximab) in the treatment of systemic lupus erythematosus
R Eisenberg
D Albert
J Stansberry
D Tsai
S Kolasinski
S Khan
Arthritis Res Ther, 5
[33] A Phase I trial of B-cell depletion with anti-CD20 monoclonal antibody (rituximab) in the treatment of systemic lupus erythematosus
Eisenberg, R
Albert, D
Stansberry, J
Tsai, D
Kolasinski, S
Khan, S
ARTHRITIS RESEARCH & THERAPY, 2003, 5 (Suppl 3) : S9 - S10
[34] Anti-CD20 depletion of B cells inhibits spontaneous autoimmune thyroiditis (SAT)
Yu, Shiguang
Braley-Mullen, Helen
FASEB JOURNAL, 2008, 22
[35] Anti-CD20 monoclonal antibody as a new treatment modality for B-cell lymphoma
Hotta, T
ACTA HISTOCHEMICA ET CYTOCHEMICA, 2002, 35 (04) : 275 - 279
[36] Anti-CD20 Antibody Therapy for B-Cell Lymphomas
Maloney, David G.
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (21) : 2008 - 2016
[37] New Anti-CD20 Monoclonal Antibodies for the Treatment of B-Cell Lymphoid Malignancies
Tadeusz Robak
Ewa Robak
BioDrugs, 2011, 25 : 13 - 25
[38] New Anti-CD20 Monoclonal Antibodies for the Treatment of B-Cell Lymphoid Malignancies
Robak, Tadeusz
Robak, Ewa
BIODRUGS, 2011, 25 (01) : 13 - 25
[39] Ofatumumab, a Novel Anti-CD20 Monoclonal Antibody for the Treatment of B-Cell Malignancies
Cheson, Bruce D.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (21) : 3525 - 3530
[40] Successful treatment of B-cell prolymphocytic leukemia with monoclonal anti-CD20 antibody
Abou Mourad, Y
Taber, A
Chehal, A
Shamseddine, A
ANNALS OF HEMATOLOGY, 2004, 83 (05) : 319 - 321

← 1 2 3 4 5 →